Lachowiez, C., Kaempf, A., Othman, J., Yun, S., Heiblig, M., Heuser, M., Shahswar, R., Patel, A., Madero-Marroquin, R., Cannova, J., Zacheo, I., Monaco, F., Drekolias, D., Zahra, F. T., Belhabri, A., Tauveron-Jalenques, U., Tavernier, E., Carré, M., Requena, G. A., Long, N., Cook, R., Traer, E., Swords, R., Saultz, J., O'Nions, J., Basheer, F., Laurie, J., Handa, S., Stein, E., Baer, M., Stock, W., Olin, R., Blum, W., Schiller, G., Lin, T., Curran, E., Huang, Y., Welkie, R., Yocum, A., Marconi, G., Madarang, E., Watts, J., Madanat, Y., Dillon, R., Loghavi, S., Zeidner, J., Pollyea, D., Bernard, E. (2025). Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax:  a multinational retrospective cohort study. Blood. https://doi.org/10.1182/blood-2025-453